Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cochlear ( (AU:COH) ) just unveiled an announcement.
Cochlear Limited announced the issuance of unquoted equity securities under its employee incentive scheme, which includes options and performance rights. This move is part of the company’s strategy to incentivize employees and align their interests with the company’s growth objectives, potentially impacting its operational dynamics and market positioning.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$312.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in implantable hearing solutions. The company is known for its cochlear implants and other hearing devices, focusing on improving the quality of life for individuals with hearing loss.
Average Trading Volume: 135,625
Technical Sentiment Signal: Buy
Current Market Cap: A$18.56B
For an in-depth examination of COH stock, go to TipRanks’ Overview page.